SGS Expands Viral Trials: ‘Less Volunteers, Less Cost to Client’

- Last updated on GMT

SGS expands clinical trial unit
SGS expands clinical trial unit
SGS says the expansion of its Belgian unit will offer a new approach in its clinical trials involving smaller sample sizes.

The viral challenge Testing facility, in Antwerp, Belgium, is to benefit from a new 12-bed quarantine facility which will allow SGS Life Science Services to conduct highly specialised clinical trials for the development of new-generation vaccines.

SGS said in a press release that this model differs from traditional community-based studies and will save clients money as the number of volunteers required to obtain meaningful results will be much lower.

Dr. Steven Ramael, SGS Life Science Services Medical Director said that “although the model does not necessarily reflect all parameters relevant to community-acquired infection, it does provide for a carefully controlled, systematic, and efficient method in which a number of variables can be controlled or even eliminated.”

Details of the facility include a negative pressure system and a dedicated laboratory containing a flow cabinet, acid cabinet, and a dedicated workspace in which to handle viral cultures. The expansion is Biosafety-Level 2-Q compliant.

Related news

Related products

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

lyo_vials

Process Development for Lyophilized Products

Baxter BioPharma Solutions | 30-Oct-2017 | Application Note

Baxter approaches formulation and process development with the intention of identifying the failure points for the product. Knowing where the product fails...

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers